Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) NFKB1 Antibodies:
anti-Human NFKB1 Antibodies:
anti-Rat (Rattus) NFKB1 Antibodies:
Go to our pre-filtered search.
Human Polyclonal NFKB1 Primary Antibody for IHC (p), WB - ABIN3043587
Kan, Zhou, Jin, Yang: Effects of PDTC on NF-?B expression and apoptosis in rats with severe acute pancreatitis-associated lung injury. in International journal of clinical and experimental medicine 2015
Show all 5 Pubmed References
Human Polyclonal NFKB1 Primary Antibody for WB - ABIN5518703
Li, Chen, Zhang, Zhu, Liu, Liang, Sun, Liao, Gong: Protective effect of glutamine-enriched early enteral nutrition on intestinal mucosal barrier injury after liver transplantation in rats. in American journal of surgery 2010
Show all 5 Pubmed References
Human Polyclonal NFKB1 Primary Antibody for WB - ABIN3042654
Zhao, Wang, Liu, Sun, Kazuhiro: Protective effects of glutamine in a rat model of endotoxemia. in Molecular medicine reports 2012
Show all 5 Pubmed References
Human Monoclonal NFKB1 Primary Antibody for WB - ABIN1882050
Meyer, Hatada, Hohmann, Haiker, Bartsch, Röthlisberger, Lahm, Schlaeger, van Loon, Scheidereit: Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha. in Proceedings of the National Academy of Sciences of the United States of America 1991
Show all 4 Pubmed References
Human Monoclonal NFKB1 Primary Antibody for ICS, WB - ABIN967610
Natoli, Saccani, Bosisio, Marazzi: Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. in Nature immunology 2005
Show all 3 Pubmed References
Human Polyclonal NFKB1 Primary Antibody for WB - ABIN518331
Elremaly, Mohamed, Mialet-Marty, Rouleau, Lavoie: Ascorbylperoxide from parenteral nutrition induces an increase of redox potential of glutathione and loss of alveoli in newborn guinea pig lungs. in Redox biology 2014
Human Polyclonal NFKB1 Primary Antibody for WB - ABIN411543
Wang, Malo, Hekimi: Elevated mitochondrial reactive oxygen species generation affects the immune response via hypoxia-inducible factor-1alpha in long-lived Mclk1+/- mouse mutants. in Journal of immunology (Baltimore, Md. : 1950) 2010
TRIM5alpha (show TRIM5 Antibodies) represses HIV-1 LTR promoter activity by negatively regulating TAK1 (show NR2C2 Antibodies)/TAB1 (show TAB1 Antibodies)/TAB2 (show TAB2 Antibodies)/TAB3 (show TAB3 Antibodies)-complex-mediated NF-kappaB activation.
NF-kappaB-mediated miR (show MLXIP Antibodies)-130a modulation is critical in lung vascular remodeling.
Inflammasome-derived exosomes activate NF-kappaB signaling in macrophages.
Genetic reduction of the P65 (show NFkBP65 Antibodies) subunit of NF-kappaB diminished chronic inflammation in dystrophic muscle.
selective knockdown of TNFR5 ameliorates glucolipotoxic induction of STAT1 (show STAT1 Antibodies) expression and NF-kappaB activity.
c-REL (show NFkBP65 Antibodies), but not IkappaBNS (show NFKBID Antibodies), controlled the generation of classical CD25 (show IL2RA Antibodies)(+)Foxp3 (show FOXP3 Antibodies)(-) precursors via direct binding to the Cd25 (show IL2RA Antibodies) locus; propose that CD4 (show CD4 Antibodies)(+)GITR (show TNFRSF18 Antibodies)(+)CD122 (show IL2RB Antibodies)(+)CD25 (show IL2RA Antibodies)(-)Foxp3 (show FOXP3 Antibodies)(-) cells represent a Treg pre-precursor population, whose transition into Treg precursors is mediated via c-REL (show NFkBP65 Antibodies)
The results presented in this study represent the first demonstration that NF-kappaB activation acts cell autonomously to protect oligodendrocytes against inflammation in animal models of MS.
proposed that TLR9 (show TLR9 Antibodies) regulates the NF-kappaB-NLRP3 (show NLRP3 Antibodies)-IL-1beta (show IL1B Antibodies) pathway negatively in Salmonella-induced NKG2D (show KLRK1 Antibodies)-mediated intestinal inflammation and plays a critical role in defense against S. typhimurium infection and in the protection of intestinal integrity
Findings suggest that increased cardiac and apoptosis-related lncRNA expression and/or cytoplasmic localization is required for efficient NF-kappaB signaling
Sirt1 (show SIRT1 Antibodies) deacetylates p65 (show NFkBP65 Antibodies) and compromises NF-kappaB activity in hepatocytes.
the cooperative role of TLR9 (show TLR9 Antibodies) with TLR2 (show TLR2 Antibodies) or TLR6 (show TLR6 Antibodies) receptors in sensing Brucella, was determined.
HBx activates NF-kappaB to promote the expression of miR1269b, which augments CDC40 (show CDC40 Antibodies) expression, contributing to malignancy in hepatocellular cancer.
Unexpectedly, a complex damage signal promotes co-localization of NF-kappaB, Smad3 (show SMAD3 Antibodies), and Nrf2 (show GABPA Antibodies) at Rev-erb (show NR1D2 Antibodies)-sensitive enhancers and drives expression of genes characteristic of multiple polarization states in the same cells.
These results suggest that the activation of NF-kappabeta by MMA(III) may participate in UROtsa cells malignant transformation through the negative regulation of PTEN (show PTEN Antibodies) expression involving p50 (show CD40 Antibodies) homodimers-mediated chromatin remodeling around the PTEN (show PTEN Antibodies) promoter.
These findings indicate that miR (show MLXIP Antibodies)-191 effectively suppresses angiogenesis by activation of the NF-kappaB signaling pathway.
NF-kappa B role in the inflammation-associated cancers [review]
Findings identify specific roles for p100 (show CUX1 Antibodies) and p105 (show CDH13 Antibodies) signaling in defining DLBCL molecular subtypes and posit MYD88 (show MYD88 Antibodies)/p100 (show CUX1 Antibodies) signaling as a regulator for B-cell activation (show BLNK Antibodies).
anti-inflammation therapy targeting Gpbar1 (show GPBAR1 Antibodies)/NF-kappaB pathway could be effective in suppressing bile acid-induced inflammation and alleviating Intrahepatic cholestasis of pregnancy-associated fetal disorders.
Findings suggest that increased cardiac and apoptosis-related lncRNA expression and/or cytoplasmic localization is required for efficient NF-kappaB signaling and is associated with the inflamed tissue state observed in human celiac disease.
p21 (show CDKN1A Antibodies) adjusts the equilibrium between p65 (show GORASP1 Antibodies)-p50 (show CD40 Antibodies) and p50-p50 NF-kappaB pathways to mediate macrophage plasticity in LPS (show IRF6 Antibodies) tolerance
Study indicate an essential role of NF-kappaB in gonadal differentiation.
This study showed that porcine epidemic diarrhea virus inhibited NF-kappaB activity and nsp1 was a potent NF-kappaB antagonist for suppression of both interferon (show IFNA Antibodies) and early production of pro-inflammatory cytokines.
inhibition of NF-kappaB increases autophagy via JNK (show MAPK8 Antibodies) signaling, and promotes steroidogenesis in porcine granulosa cells
SIRT1 (show SIRT1 Antibodies), p53 (show TP53 Antibodies) and NF-kappaB are involved in the control of both the proliferation and the apoptosis of ovarian cells.
porcine CD74 (show CD74 Antibodies) significantly enhanced the inflammatory response by regulating the NF-kappaB signalling pathway during PCV2 infection, which suggests that porcine CD74 (show CD74 Antibodies) may be implicated in the pathogenesis of PCV2 infection.
These results suggest that trans-10, cis (show CISH Antibodies)-12-conjugated linoleic acid can modulate TNF-alpha (show TNF Antibodies) production and NF-kappa B expression by a PPARgamma (show PPARG Antibodies)-dependent pathway in porcine peripheral blood mononuclear cells.
Taken together, Staphylococcus aureus induces TGF-beta1 (show TGFB1 Antibodies) and bFGF (show FGF2 Antibodies) expression through the activation of AP-1 (show JUN Antibodies) and NF-kappaB in bovine mammary gland fibroblasts.
Data indicate the involvement of PKC-alpha (show PKCa Antibodies) in proMMP-2 activation and inhibition of TIMP-2 (show TIMP2 Antibodies) expression by NF-kappaB-MT1-MMP (show MMP14 Antibodies)-dependent and -independent pathway.
MMP-1 (show MMP1 Antibodies) promotes VEGFR2 (show KDR Antibodies) expression and proliferation of endothelial cells through stimulation of PAR-1 (show F2R Antibodies) and activation of NF-kappaB
dynamic compression stimulates cell proliferation and proteoglycan (show Vcan Antibodies) synthesis in the presence of IL-1beta (show IL1B Antibodies) and/or inhibitors of the MAPKs and NFkappaB and AP-1 (show JUN Antibodies) signalling pathways
This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. Two transcript variants encoding different isoforms have been found for this gene.
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)
, nuclear factor NF-kappa-B p105 subunit
, nuclear factor kappa-B, subunit 1
, nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
, nuclear factor NF-kappa-B p105 subunit-like
, DNA-binding factor KBF1
, NF kappaB1
, NF-kappa-B1 p84/NF-kappa-B1 p98
, NF-kappaB p50
, nuclear factor kappaB p50
, nuclear factor of kappa light chain gene enhancer in B-cells 1, p105
, nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, p105
, nuclear factor-kappaB p50
, p50 subunit of NF kappaB
, p50 subunit of NF-kappaB
, DNA binding factor KBF1
, nuclear factor NF-kappa-B p50 subunit
, nuclear factor kappa-B DNA binding subunit
, BICD-related protein 1
, NF-kB1 precursor protein
, bicaudal D-related protein 1
, coiled-coil domain-containing protein 64A
, NF-kB p50 subunit
, nuclear factor kappa-B 1
, nuclear factor of kappa light polypeptide enhancer in B-cells 1